N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide

C45H50Cl2N14O7 — CID 167157821

IUPACN-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide
SMILESCOC1CC(c2nc(Nc3ccc4[nH]ncc4c3Cl)n(C)n2)=CC=C1OCC(=O)NC1(O)CC1n1ncc2c(Cl)c(Nc3nc(C4=CC=C(OCC(=O)NC(C)(C)C)C(OC)C4)nn3C)ccc21
InChIInChI=1S/C45H50Cl2N14O7/c1-44(2,3)54-36(62)21-67-31-14-8-23(16-33(31)65-6)41-53-43(60(5)58-41)51-29-12-13-30-26(39(29)47)20-49-61(30)35-18-45(35,64)55-37(63)22-68-32-15-9-24(17-34(32)66-7)40-52-42(59(4)57-40)50-28-11-10-27-25(38(28)46)19-48-56-27/h8-15,19-20,33-35,64H,16-18,21-22H2,1-7H3,(H,48,56)(H,54,62)(H,55,63)(H,50,52,57)(H,51,53,58)
InChIKeyVYRODOWWJMUFBK-UHFFFAOYSA-N
MW969.89 g/mol
LogP5.73
Rot. Bonds16

About N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide

N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide (PubChem CID 167157821) has the molecular formula C45H50Cl2N14O7 and a molecular weight of 969.89 g/mol. Its IUPAC name is N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide.

Molecular Properties

Compound NameN-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide
PubChem CID167157821
Molecular FormulaC45H50Cl2N14O7
Molecular Weight969.89 g/mol
Exact Mass968.34
IUPAC NameN-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide
SMILESCOC1CC(c2nc(Nc3ccc4[nH]ncc4c3Cl)n(C)n2)=CC=C1OCC(=O)NC1(O)CC1n1ncc2c(Cl)c(Nc3nc(C4=CC=C(OCC(=O)NC(C)(C)C)C(OC)C4)nn3C)ccc21
InChIInChI=1S/C45H50Cl2N14O7/c1-44(2,3)54-36(62)21-67-31-14-8-23(16-33(31)65-6)41-53-43(60(5)58-41)51-29-12-13-30-26(39(29)47)20-49-61(30)35-18-45(35,64)55-37(63)22-68-32-15-9-24(17-34(32)66-7)40-52-42(59(4)57-40)50-28-11-10-27-25(38(28)46)19-48-56-27/h8-15,19-20,33-35,64H,16-18,21-22H2,1-7H3,(H,48,56)(H,54,62)(H,55,63)(H,50,52,57)(H,51,53,58)
InChIKeyVYRODOWWJMUFBK-UHFFFAOYSA-N
XLogP5.73
TPSA247.33 Ų
H-Bond Donors6
H-Bond Acceptors18
Rotatable Bonds16
Heavy Atoms68
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500969.89
LogP ≤ 55.73
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide?
The IUPAC name of N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide (CID 167157821) is N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide.
What is the SMILES notation for N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide?
The canonical SMILES for N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide is COC1CC(c2nc(Nc3ccc4[nH]ncc4c3Cl)n(C)n2)=CC=C1OCC(=O)NC1(O)CC1n1ncc2c(Cl)c(Nc3nc(C4=CC=C(OCC(=O)NC(C)(C)C)C(OC)C4)nn3C)ccc21.
What is the InChIKey of N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide?
The InChIKey is VYRODOWWJMUFBK-UHFFFAOYSA-N. The full InChI is InChI=1S/C45H50Cl2N14O7/c1-44(2,3)54-36(62)21-67-31-14-8-23(16-33(31)65-6)41-53-43(60(5)58-41)51-29-12-13-30-26(39(29)47)20-49-61(30)35-18-45(35,64)55-37(63)22-68-32-15-9-24(17-34(32)66-7)40-52-42(59(4)57-40)50-28-11-10-27-25(38(28)46)19-48-56-27/h8-15,19-20,33-35,64H,16-18,21-22H2,1-7H3,(H,48,56)(H,54,62)(H,55,63)(H,50,52,57)(H,51,53,58).
What are the key properties of N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide?
N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide has a molecular weight of 969.89 g/mol, XLogP of 5.73, 16 rotatable bonds, 6 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[5-[[5-[4-[2-(tert-butylamino)-2-oxoethoxy]-5-methoxycyclohexa-1,3-dien-1-yl]-2-methyl-1,2,4-triazol-3-yl]amino]-4-chloroindazol-1-yl]-1-hydroxycyclopropyl]-2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-6-methoxycyclohexa-1,3-dien-1-yl]oxyacetamide is sourced from PubChem (CID 167157821), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).